Lapidus Stanley's Form 4 filing
Lucid Diagnostics Inc. (LUCD) · filed Sep 22, 2023
- Accession no.
- 0001062993-23-018421
- Filed
- Sep 22, 2023
- Trade date
- Sep 20-21, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.67K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001062993-23-018551 (Sep 27, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lapidus StanleyCIK 0001678195 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 20, 2023 | Common stock | SSaleDisposed | −3,405 | $1.45 | −$4,937.25 | 132,051 | Direct | |
| Sep 20, 2023 | Common stock | SSaleDisposed | −412 | $1.44 | −$593.28 | 131,639 | Direct | |
| Sep 21, 2023 | Common stock | SSaleDisposed | −100 | $1.44 | −$144 | 131,539 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.